Evidence map›Paper›PMID 40895613›Full record

ArticleInfection and drug resistance2025

Investigation into Antibiotic Resistance Profiles of

Mingqiu Liu, Feng Sun, Yongli Qi, Wenjing Qi, Junyi Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingqiu LiuDepartment of Otolaryngology, Affiliated People's Hospital of Shandong First Medical University, Shandong, Jinan, People's Republic of China.
Feng SunDepartment of Otolaryngology, Affiliated People's Hospital of Shandong First Medical University, Shandong, Jinan, People's Republic of China.
Yongli QiDepartment of Otolaryngology, Affiliated People's Hospital of Shandong First Medical University, Shandong, Jinan, People's Republic of China.
Wenjing QiDepartment of Otolaryngology, Affiliated People's Hospital of Shandong First Medical University, Shandong, Jinan, People's Republic of China.
Junyi LiDepartment of Otolaryngology, Affiliated People's Hospital of Shandong First Medical University, Shandong, Jinan, People's Republic of China.ORCID 0009-0001-4483-0079

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to comprehensively investigate the antibiotic resistance characteristics of Methods: A retrospective analysis was conducted on 180 CRS patients admitted to our hospital between February 2022 and July 2024. Nasal secretion samples were collected upon admission for Results: Among 180 isolated Conclusion: MRSA exhibits pronounced resistance to commonly used antibiotics in CRS treatment. Clinicians should prioritize targeted screening for high-risk patients, optimize antibiotic stewardship, and enhance postoperative nasal function management. Implementing a multifaceted approach-including early risk assessment, standardized antibiotic use, and intensified follow-up care-can effectively mitigate MRSA infection risks and improve overall treatment outcomes for CRS patients.

Indexed as

antibiotic resistancechronic rhinosinusitismethicillin-resistant staphylococcus aureusrisk factorsstaphylococcus aureus infection

Identifiers

PMID40895613
PMCPMC12399101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.